Molecular Medicine
A section of Current Issues in Molecular Biology (ISSN 1467-3045).
Section Information
The “Molecular Medicine” section of the Current Issues in Molecular Biology (CIMB) journal publishes the very best scientific articles in molecular biology. In addition to molecular biology, this journal is also interested in receiving articles that explore new molecular biology-based techniques and tools that advance the field of Molecular Medicine.
This journal urges authors to submit articles that unravel complex disease mechanisms and create RNA data to predict drug responses. In addition, authors are welcome to submit in vivo preclinical animal models to predict, at the molecular level, drugs that can reverse disease states.
Topic of interest includes (but are not necessarily limited to) the following:
- Understanding the molecular mechanism of the disease process;
- Use of transgenic animals to study disease models;
- Tools to study genome editing, machine learning, omics, RNA editing, and computational software to study metabolism;
- Epigenetic modification, genome regulation, and replication;
- Transcription factor regulation;
- Identifying genetic errors in disease;
- Molecular Cellular Pathways in animals, plants, and bacteria;
- Molecular interventions and methodologies;
- Development of novel methods of treatment/therapeutics.
Keywords
- pathogenesis
- angiogenesis
- autoimmune diseases
- inflammatory
- cancer
- cardiovascular diseases
- development and differentiation
- endocrinology
- genetics
- epigenetics
- hematology
- hypoxia research
- immunology
- infectious diseases
- metabolic disorders
- neuroscience of diseases
- regenerative medicine
- prevention
- therapeutics and stem cell research
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Molecular Mechanisms Driving Cancer Progression and Metastasis (Deadline: 20 September 2026)
- Molecular Innovations in Drug Repositioning for Cancer Therapy (Deadline: 30 September 2026)
- Molecular Mechanisms Underlying Fatty Liver Disease: From Pathogenesis to Treatment, 3rd Edition (Deadline: 30 September 2026)
- Innovative Models for SARS-CoV-2 Pathogenesis (Deadline: 30 September 2026)
- Stem Cell-Derived Cells and Bioengineering: Molecular Bases in Regeneration and Disease Research (Deadline: 30 September 2026)
- Molecular Mechanisms and Therapeutic Advances in Hypertension Management and Vascular Health (Deadline: 20 October 2026)
- Epigenetics and Chromatin Remodeling in Cancer (Deadline: 31 October 2026)
- Hyperlipidemia and Molecular Mechanism in Human and Animals (Deadline: 31 October 2026)
- Molecular Mechanism Influencing the Short- and Long-Term Toxicity of Cancer Treatments (Deadline: 31 October 2026)
- Molecular Research on Metabolic Disease (Deadline: 31 October 2026)
- Genetics and Genomics Research of Autism Spectrum Disorders (Deadline: 31 October 2026)
- Molecular Mechanisms and Reparative Therapeutic Strategies in Neurodegenerative Diseases (Deadline: 31 October 2026)
- Gynecological Cancers: From Molecular Biology to Therapeutic Advances (Deadline: 31 October 2026)
- Molecular Mechanisms and Therapeutic Targets in Epilepsy (Deadline: 31 October 2026)
- Early Molecular Diagnosis and Comprehensive Treatment of Tumors, 2nd Edition (Deadline: 31 October 2026)
- Scoliosis and Spinal Disorders: Molecular Biomarkers and Therapeutic Strategies (Deadline: 31 October 2026)
- Molecules at Play in Cardiovascular Diseases (Deadline: 31 October 2026)
- Molecular Mechanisms in Cancer Treatment and Anticancer Drugs (Deadline: 30 November 2026)
- Molecular Insights into Multifactorial Causes of Insulin Resistance in Obesity, 2nd Edition (Deadline: 30 November 2026)
- Exploring Novel Therapeutic Targets for Neuropsychiatric Disorders: Current Research and Future Direction (Deadline: 30 November 2026)
- Molecular Basis of Autoimmune Diseases (Deadline: 30 November 2026)
- Nutrition and Immune Function in Disease: From Mechanisms to Precision Medicine (Deadline: 30 November 2026)
- State-of-the-Art Molecular Skin Research in the Republic of Korea (Deadline: 30 November 2026)
- Pathogenesis, Diagnosis and Treatment of Skin and Sexually Transmitted Diseases (Deadline: 30 November 2026)
- Targeted Therapeutic Approaches in Cancer: Combining Natural Compounds and Conventional Drugs (Deadline: 30 November 2026)
- Gastrointestinal Cancers: From Pathogenesis to Treatment (Deadline: 30 November 2026)
- Nanomedicines in Cancers Targeting and Therapy (Deadline: 30 November 2026)
- Phytochemical-Based Therapeutics: Emerging Mechanisms and Biomedical Applications (Deadline: 30 November 2026)
- Gene Expression and Regulation in Cancer (Deadline: 30 November 2026)
- Molecular Mechanisms of Intervertebral Disc Degeneration and Regeneration (Deadline: 10 December 2026)
- Molecular Research on Metabolic Aberration-Driven Carcinogenesis (Deadline: 30 December 2026)
- Cancer-Associated Remodeling of Functional Molecular Pathways (Deadline: 31 December 2026)
- Molecular Mechanisms in Lung Diseases: From Pathogenesis to Therapeutic Targets (Deadline: 31 December 2026)
- DNA Methylation in Cancer—Biomarkers and Therapeutic Targets (Deadline: 31 December 2026)
- Immune Signatures and Biomarkers for Precision Medicine in Inflammatory Bowel Disease (Deadline: 31 December 2026)
- Rewiring the Injured Brain: Synaptic Plasticity and Circuit Modulation After Stroke and Brain Injury (Deadline: 31 December 2026)
- Molecular Neuropsychiatry: Target Discovery for Mental Disorders (Deadline: 31 December 2026)
- Molecular Pathways and Therapeutic Targets in Endometriosis (Deadline: 31 December 2026)
- Multi-Omics Integration for Precision Medicine: From Pathogenesis, Diagnosis to Treatment (Deadline: 31 December 2026)
- Molecular Insights and Unique Characteristics in Adolescent and Young Adult Oncology (Deadline: 31 December 2026)
- Molecular Mechanisms, Diet and Therapeutic Interventions in Neurological Disorders (Deadline: 31 December 2026)
- Allergic Diseases: Molecular Pathways and Pathogenesis (Deadline: 31 December 2026)
- Molecular Mechanism of HPV’s Involvement in Cancers, 2nd Edition (Deadline: 31 December 2026)
- Biomedical Technology and Brain Metabolism (Deadline: 31 December 2026)
- Molecular Mechanisms and Biomarker Discovery in Neurodegenerative Disorders (Deadline: 31 December 2026)
- Molecular Insights, Biomarkers, and Clinical Diagnosis in Cancer Biology and Treatment (Deadline: 31 January 2027)
- Molecular Mechanisms of Liver Diseases and Potential Therapeutic Targets (Deadline: 31 January 2027)
- Cerebrovascular Diseases: From Pathogenesis to Treatment, 2nd Edition (Deadline: 31 January 2027)
- Molecular Mechanisms and Pharmacological Underlying Cardiorenal Diseases (Deadline: 31 January 2027)
- Future Challenges of Targeted Therapy of Cancers, 3rd Edition (Deadline: 31 January 2027)
- Molecular Biology in Drug Design and Precision Therapy, 2nd Edition (Deadline: 31 January 2027)
- Molecular Targeted Cancer Therapy: Action Mechanisms and Novel Biomarkers (Deadline: 31 January 2027)
- Molecular Mechanisms and Therapeutic Targets in Bone Biology and Cancer (Deadline: 31 January 2027)
- New Discoveries and Mechanistic Insights in Future Cancer Therapies (Deadline: 31 January 2027)
- Advances in Molecular Biology Methods in Hepatology Research, 2nd Edition (Deadline: 31 January 2027)
- Innovations in Nanomedicine and Bio-Nanotechnology (Deadline: 31 January 2027)
- Cardiovascular Disease: From Molecular Mechanisms to Therapeutic Innovations, 2nd Edition (Deadline: 31 January 2027)
- Regulatory Factors and Signaling Pathways Controlling Ovarian Development and Function (Deadline: 31 January 2027)
- Decoding the Molecular Basis of Therapy Resistance in Cancer: Mechanisms, Biomarkers, and Emerging Targets (Deadline: 28 February 2027)
- The Significance of Transcription Factors, miRNAs, and lncRNAs in Anticancer Drug Development, 2nd Edition (Deadline: 28 February 2027)
- Advanced Molecular Research on Hypertensive Disorders of Pregnancy—2nd Edition (Deadline: 28 February 2027)
- Molecular Mechanisms, Biomarkers, and New Treatment for Kidney Diseases (Deadline: 28 February 2027)
- Advances in Molecular Veterinary Medicine: Pathogenesis, Diagnostics, and Innovative Treatment Strategies (Deadline: 28 February 2027)
- Advances in Molecular Immunology: Molecular Pathways and Therapeutic Targets (Deadline: 28 February 2027)
- State-of-the-Art Advances in Molecular Mechanisms and Management of Preeclampsia in USA (Deadline: 28 February 2027)
- Molecular and Immunological Underpinnings of Atherosclerosis and Related Cardiovascular Diseases (Deadline: 28 February 2027)
- Molecular Insights and Therapeutic Advances in Hematological Disorders, 2nd Edition (Deadline: 28 February 2027)
- Molecular Mechanisms and Biomarkers in Asthma: From MicroRNA to Immune Modulation (Deadline: 28 February 2027)
- Molecular Characteristics and Diagnostic Biomarkers in Tumors (Deadline: 28 February 2027)
- Tumor Immunotherapy: Mechanisms and Translation (Deadline: 28 February 2027)
- Molecular Mechanisms and Treatment of Kidney Diseases (Deadline: 25 March 2027)
- Inflammation and Immune Dysregulation in Cardiovascular Diseases: Molecular Mechanisms and Therapeutic Strategies (Deadline: 31 March 2027)
- State-of-the-Art Molecular Pathology and Therapeutics in Romania (Deadline: 31 March 2027)
- Molecular Pathogenesis of Allergic Diseases (Deadline: 31 March 2027)
- Crush Syndrome: Molecular Mechanisms and Therapeutic Applications (Deadline: 31 March 2027)
- Molecular Mechanisms and Targeted Therapies in Respiratory Diseases (Deadline: 31 March 2027)
- Molecular Markers of Tumor Response and Toxicity of Antitumor Therapy (Deadline: 31 March 2027)
- Neurochemical and Biochemical Mechanisms of Depressive Disorders (Deadline: 31 March 2027)
- Cellular and Molecular Mechanisms of Epilepsy (Deadline: 31 March 2027)
- Molecular Mechanisms, Biomarkers, and Emerging Therapeutic Strategies in Cancer (Deadline: 30 April 2027)
- Molecular and Cellular Mechanisms of Epilepsy: Integrative Multi-Omics, Spatial Biology, and Computational Approaches (Deadline: 30 April 2027)
- Oxidative Stress in Cancer Biology (Deadline: 30 April 2027)
- Molecular and Cellular Mechanisms of Autoimmune Diseases: From Immune Dysregulation to Precision Therapy (Deadline: 30 April 2027)
- Precision Molecular Oncology: From Tumor Biomarker Discovery to Next-Generation Drug Delivery (Deadline: 30 April 2027)
- Novel Therapeutic Approaches for Targeting Cardiac Fibrosis in Heart Failure (Deadline: 30 April 2027)
- Unraveling the Role of Epigenetics and Molecular Genetics in Disease Progression via the Gut–Brain Axis (Deadline: 30 June 2027)
Topical Collections
Following topical collections within this section are currently open for submissions:
